MENU
+Compare
MBOT
Stock ticker: NASDAQ
AS OF
Jan 13, 04:59 PM (EDT)
Price
$2.13
Change
-$0.01 (-0.47%)
Capitalization
143.05M

MBOT Microbot Medical Forecast, Technical & Fundamental Analysis

Microbot Medical Inc is a breakthrough medical device company... Show more

Industry: #Biotechnology
MBOT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MBOT with price predictions
Jan 12, 2026

MBOT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MBOT turned positive on January 08, 2026. Looking at past instances where MBOT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 71 cases where MBOT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MBOT advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

MBOT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MBOT as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MBOT moved below its 50-day moving average on January 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MBOT crossed bearishly below the 50-day moving average on December 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MBOT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MBOT entered a downward trend on January 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.829) is normal, around the industry mean (11.743). P/E Ratio (0.000) is within average values for comparable stocks, (168.065). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.574). MBOT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.000) is also within normal values, averaging (113.462).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MBOT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBOT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
MBOT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MBOT is expected to report earnings to -7 cents per share on February 25

Microbot Medical MBOT Stock Earnings Reports
Q4'25
Est.
$-0.07
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.01
The last earnings report on November 07 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 482.33K shares outstanding, the current market capitalization sits at 143.05M.
A.I. Advisor
published General Information

General Information

a company, which specializes in the research, design, development and commercialization of micro-robotics assisted medical technologies

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
288 Grove Street
Phone
+1 781 875-3605
Employees
22
Web
https://microbotmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLASF9.020.20
+2.27%
Glass House Brands Inc.
SGSOF119.761.26
+1.06%
SGS SA
CCHI0.17N/A
N/A
Cambridge Capital Holdings, Inc.
JUMSF27.50N/A
N/A
Jumbo SA
CSDX0.25-0.02
-7.41%
CS Diagnostics Corp.

MBOT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with BNGO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then BNGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+1.91%
BNGO - MBOT
35%
Loosely correlated
+0.63%
CORBF - MBOT
33%
Loosely correlated
N/A
RCEL - MBOT
33%
Poorly correlated
+0.59%
OTCFF - MBOT
32%
Poorly correlated
+0.41%
AIMD - MBOT
32%
Poorly correlated
+2.15%
More

Groups containing MBOT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+1.91%
Pharmaceuticals
category (383 stocks)
28%
Poorly correlated
+0.17%
Pharmaceuticals: Other
category (106 stocks)
27%
Poorly correlated
-0.54%